Chris Ellis
Direttore operativo presso Vaccitech (UK) Ltd.
Patrimonio netto: 182 $ in data 30/04/2024
Provenienza dei contatti di primo grado di Chris Ellis
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 18 | |
Vaccitech (UK) Ltd.
 Vaccitech (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Vaccitech (UK) Ltd. researches in and develops seasonal flu vaccines. It engages in clinical programs for universal influenza and prostate cancer, MERS, and preclinical programs for other therapeutic infectious diseases indications. The company was founded by Adrian Hill and Sarah Gilbert and is headquartered in Oxford, the United Kingdom.
13
| Holding Company | Miscellaneous Commercial Services | 13 |
Akamis Bio Ltd.
 Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom.
1
| Holding Company | Biotechnology | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Chris Ellis tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Rochester Christian University | College/University | Corporate Officer/Principal | |
M&G Investment Management Ltd.
 M&G Investment Management Ltd. Investment ManagersFinance M&G Investment Management Ltd. (MAGIM) is the asset management subsidiary of MG FA Ltd., ultimately owned by M&G Plc (LON: MNG) in Great Britain. Formerly known as Prudential Investment Management Ltd., the firm was founded in 1968 and is headquartered in London. MAGIM provides investment management for a broad range of clients, with a product range that includes segregated mandates for institutions as well as retail mutual funds for individuals. | Investment Managers | Portfolio Manager-Equities | |
Aeras Global TB Vaccine Foundation
 Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Miscellaneous Commercial Services | Chief Executive Officer | |
| UBS GROUP AG | Investment Managers | Corporate Officer/Principal | |
| University of Virginia | College/University | Doctorate Degree | |
| University of Oxford | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Cambridge | College/University | Graduate Degree | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Chief Operating Officer | |
| INSEAD | College/University | Undergraduate Degree | |
| University of California, Davis | College/University | Corporate Officer/Principal | |
| Williams College | College/University | Undergraduate Degree | |
| International Institute for Management Development | College/University | Undergraduate Degree | |
| Plekhanov Russian University of Economics | College/University | Graduate Degree | |
| ESSEC Business School | College/University | Masters Business Admin | |
| Université Claude Bernard Lyon 1 | College/University | Doctorate Degree | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Sanofi Pasteur
 Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Biotechnology | Sales & Marketing | |
| AMOÉBA | Household/Personal Care | Director/Board Member | |
Dymon Asia Capital (Singapore) Pte Ltd.
 Dymon Asia Capital (Singapore) Pte Ltd. Investment ManagersFinance Dymon Asia Capital (Singapore) Pte Ltd. (Dymon Asia) is an Asian-focused alternative investment management firm headquartered in Singapore. The firm was founded by Danny Yong and Keith Tan in 2008 and is a subsidiary of Dymon Asia Capital Ltd. in Cayman Islands. They manage the Dymon Asia Multi-Strategy Investment Fund (MSIF), Dymon Asia China Absolute Return Bond Fund (CARBF) and Dymon Asia China Absolute Return Bond Fund (CARBF). Dymon Asia is a signatory to the UN Principles for Responsible Investment (UNPRI). | Investment Managers | Portfolio Manager-Equities | |
| CANSINO BIOLOGICS INC. | Biotechnology | Director/Board Member | |
Agalimmune Ltd.
 Agalimmune Ltd. Pharmaceuticals: MajorHealth Technology Part of BioLineRx Ltd., Agalimmune Ltd. is a British company that develops anti-cancer immunotherapy technology. The company is based in London, UK. The company was founded by Charles Campbell Roberts and Graham Griffiths. The CEO is Mike Westby. Agalimmune was acquired by BioLineRx Ltd. on March 23, 2017 for $6.05 million. | Pharmaceuticals: Major | Founder | |
Univercells SA
 Univercells SA BiotechnologyHealth Technology Univercells SA designs single-use cost-efficient bioprocess solutions to open the next chapter in bio manufacturing. The company was founded by Jose Castillo, Guillaume De Viron and Hugues Bultot in 2013 and is headquartered in Gosselies, Belgium. | Biotechnology | Director/Board Member | |
AJ Biologics Sdn. Bhd.
 AJ Biologics Sdn. Bhd. BiotechnologyHealth Technology AJ Biologics Sdn. Bhd develops and manufactures biological products. It specializes in vaccine formulations. The company is headquartered in Kuala Lumpur, Malaysia. | Biotechnology | Chief Executive Officer | |
| University of Reading Malaysia | College/University | Undergraduate Degree | |
Schering-Plough SAS
 Schering-Plough SAS Pharmaceuticals: MajorHealth Technology Founded in 1900, Schering-Plough SAS is a French pharmaceutical company that manufactures pharmaceutical products. Part of Merck & Co., Inc., the company is based in Puteaux, France. | Pharmaceuticals: Major | Director/Board Member | |
CUBE Labs Srl
 CUBE Labs Srl Investment ManagersFinance Cube Labs Srl (Cube Labs) is a venture capital subsidiary of Cube Labs SpA founded in 2013 by Filippo Surace and Renato del Grosso. The firm is headquartered in Rome, Italy. | Investment Managers | Consultant / Advisor | |
CompareEuropeGroup Ltd.
 CompareEuropeGroup Ltd. Financial ConglomeratesFinance CompareEuropeGroup Ltd. operates as a financial management platform for insurance, banking, and telco products. It has offices in Denmark, Portugal, Finland, Belgium and Norway. The firm operates independent online comparison tools for insurance, personal loans, credit cards, broadband subscriptions and other home services. The company was founded by Antonio Gagliardi, Thomas Munk, and Mads Faurholt-Jorgensen in 2015 and is headquartered in London, the United Kingdom. | Financial Conglomerates | Director of Finance/CFO | |
Exscientia AI Ltd.
 Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Generic | Director of Finance/CFO | |
Virometix AG
 Virometix AG Pharmaceuticals: MajorHealth Technology Virometix AG is a Swiss biotechnology company that focuses on developing vaccines and immunotherapeutic drugs for the prevention and treatment of infections and cancer. Virometix is based in Schlieren, CH. The private company's mission is to address the growing medical need for vaccines to combat infectious and chronic human diseases. The company was founded by John Anthony Robinson, and the CEO is Anna Sumeray. | Pharmaceuticals: Major | Chairman | |
Theolytics Ltd.
 Theolytics Ltd. BiotechnologyHealth Technology Theolytics Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
Evox Therapeutics Ltd.
 Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
Argonaut Therapeutics Ltd.
 Argonaut Therapeutics Ltd. BiotechnologyHealth Technology Argonaut Therapeutics Ltd. develops novel epigenetic therapies. It targets abnormal arginine methylation in cancer. The company was founded by Nicholas La Thangue and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member | |
| Alma Biotherapeutics | Chairman | ||
| Mrgn Advisors | Chief Executive Officer | ||
| Drug Abuse Sciences | Chief Executive Officer | ||
Health Technology Holding Srl
 Health Technology Holding Srl Investment ManagersFinance Health Technology Holding Srl (HTC), is a venture capital subsidiary of Gefim SpA founded in 2019. The firm is headquartered in Milan, Italy. | Investment Managers | Chairman | |
Kupando GmbH
 Kupando GmbH BiotechnologyHealth Technology Kupando GmbH is a German biopharmaceutical company that develops agonists to stimulate innate immunity. The company is based in Schoenefeld, Germany. The company was founded in 2018 by Johanna Holldack, who has been the CEO since 2018. | Biotechnology | Chairman | |
Limula Biotech
 Limula Biotech Miscellaneous Commercial ServicesCommercial Services Limula Biotech operates as an automated gene therapy manufacturing platform. | Miscellaneous Commercial Services | Director/Board Member | |
Adiposs SA
 Adiposs SA Medical SpecialtiesHealth Technology Adiposs SA is a Swiss medical imaging company that has developed imagebat-enhanced CT scan technology. The company is based in Plan-les-Ouates, Switzerland. The technology is fast, pain-free, and can be made available in every hospital and organization worldwide that provides CT scans. The company's co-inventor, Andrej Babic, has co-authored more than 30 scientific papers and holds several patents in the fields of medical imaging, photodynamic therapy, and nanotechnology. The company's team includes experts in preclinical development, clinical trials, and drug development across multiple therapeutic areas. Adiposs was founded by Nathalie Stransky-Heilkron, Andrej Babic, and Justyna Plewka Ma. Andrej Babic has been the CEO since incorporation. | Medical Specialties | Chairman | |
| MYCB1 Group BV | Chairman | ||
| FREIGHTOS LIMITED | Internet Software/Services | Director/Board Member | |
| MRGN Advisors SARL | Chief Executive Officer | ||
| MYCB1 BV | Chairman | ||
Kyowa Kirin Pharmaceutical Development Ltd.
 Kyowa Kirin Pharmaceutical Development Ltd. Miscellaneous Commercial ServicesCommercial Services Kyowa Kirin Pharmaceutical Development Ltd. engages in developing pharmaceutical products. The company was founded on December 31, 1996 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| MET Parking Services Ltd. | Director/Board Member |
Statistiche
Distribuzione geografica
| Regno Unito | 14 |
| Stati Uniti | 11 |
| Francia | 8 |
| Svizzera | 7 |
| Malesia | 3 |
Settori
| Health Technology | 18 |
| Consumer Services | 13 |
| Finance | 9 |
| Commercial Services | 5 |
| Consumer Non-Durables | 2 |
Posizioni
| Director/Board Member | 78 |
| Corporate Officer/Principal | 30 |
| Independent Dir/Board Member | 22 |
| Chairman | 18 |
| Undergraduate Degree | 15 |
Contatti più connessi
| Insiders | |
|---|---|
| Pierre Armand Morgon | 29 |
| Karen Dawes | 21 |
| Anne Phillips | 14 |
| Paolo Augusto Paoletti | 13 |
| William Enright | 12 |
| Steven N. Chatfield | 11 |
| Andrew James Mclean | 10 |
| Thomas Evans | 9 |
| Joseph Scheeren | 9 |
| Robin Wright | 8 |
| Margaret Marshall | 6 |
| Carl David Vine | 6 |
| Georgy Egorov | 6 |
| Alex Hammacher | 6 |
| Graham Griffiths | 5 |
- Borsa valori
- Insiders
- Chris Ellis
- Connessioni Società